What are the uses and dosages of Mometasone (mometasone furoate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mometasone Furoate: Uses and Dosages

Mometasone furoate is a medium-potency synthetic corticosteroid available in multiple formulations for treating various inflammatory conditions, with specific dosages and indications depending on the formulation and condition being treated. 1, 2

Topical Formulations

Indications

  • Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses 1
  • Effective for treating:
    • Atopic dermatitis 2
    • Seborrheic dermatitis 2
    • Psoriasis vulgaris 2
    • Scalp psoriasis 2

Dosage and Administration

  • Topical solution/lotion (0.1%): Apply a few drops to affected areas once daily and massage lightly until it disappears 1
  • For most effective use, hold nozzle close to affected area and gently squeeze 1
  • Treatment duration: Discontinue when control is achieved; reassess diagnosis if no improvement after 2 weeks 1
  • Not recommended for pediatric patients under 12 years of age 1

Special Considerations

  • Should not be used with occlusive dressings unless directed by physician 1
  • Avoid application in diaper area if patient requires diapers or plastic pants (may constitute occlusive dressing) 1
  • Can be used in combination with other agents:
    • Addition of salicylic acid to mometasone is safe for treating moderate to severe psoriasis (BSA ≤20%) 3
    • Combination with emollients can help reduce itching, desquamation, and total body surface area involvement in psoriasis 3

Intranasal Formulation

Indications

  • Seasonal and perennial allergic rhinitis 3, 4
  • Nasal polyps (age ≥18 years) 3

Dosage and Administration

  • Nasal spray (50 μg per spray):
    • Ages 2-11 years: 1 spray per nostril once daily 3
    • Ages ≥12 years: 2 sprays per nostril once daily 3
    • Adults with nasal polyps: 2 sprays per nostril twice daily 3

Efficacy

  • Onset of action approximately 7 hours in seasonal allergic rhinitis 4
  • As effective as twice-daily beclomethasone dipropionate or once-daily fluticasone propionate in perennial allergic rhinitis 4
  • More effective than placebo in controlling symptoms of moderate to severe seasonal or perennial allergic rhinitis 4

Inhaled Formulation for Asthma

Indications

  • Control of mild to severe persistent asthma in adults and adolescents 5

Dosage and Administration

  • Dry powder inhaler (200 μg per inhalation):
    • Dosage varies based on asthma severity 3
    • Once-daily administration of 400 μg appears as effective as twice-daily administration of 200 μg 5

Efficacy

  • Improves lung function, asthma symptom scores, and reduces rescue medication use 5
  • Can reduce requirements for oral corticosteroids in patients with oral corticosteroid-dependent asthma 5

Advantages and Safety Profile

Advantages

  • Once-daily application for topical formulations (versus multiple daily applications for many other corticosteroids) 2, 6
  • Low potential for causing primary sensitization and cross-reactions with other topical glucocorticoids 2
  • Minimal systemic activity when used as directed 2, 4
  • Low atrophogenic potential compared to other glucocorticoids in its class 2

Common Side Effects

  • Topical: Transient mild to moderate local effects such as burning, stinging, folliculitis, dryness, acneiform eruptions 2
  • Intranasal: Headache, pharyngitis, epistaxis, nasal irritation/burning 3, 4
  • Inhaled: Oral candidiasis, headache, pharyngitis, dysphonia 5

Special Populations

Pregnancy and Lactation

  • Moisturizers (which can be used with mometasone) are considered safe during pregnancy and lactation 3

Pediatric Use

  • Not recommended for topical use in children under 12 years 1
  • Intranasal formulation approved for children as young as 2 years 3
  • Salicylic acid (sometimes combined with mometasone) should be avoided in children due to greater risk of systemic absorption and toxicity 3

Clinical Pearls

  • For pruritus treatment, topical mometasone furoate 0.1% ointment or betamethasone valerate 0.1% ointment can be considered for moderate to high-potency steroid needs 3
  • For psoriasis, combination therapy of mometasone with tazarotene may provide synergistic effects, increasing efficacy during therapy and duration of therapeutic effect 3
  • In allergic rhinitis, patient preference between oral antihistamines and nasal steroids like mometasone should be considered to promote better adherence to therapy 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.